![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Staehler, Michael; Stöckle, Michael; Christoph, Daniel C.; Stenzl, Arnulf; Potthoff, Karin; Grimm, Marc-Oliver; Klein, Dunja; Harde, Johanna; Brüning, Fabian; Goebell, Peter J.; Augustin, Marinela; Roos, Frederik; Benz-Rüd, Iris; Marschner, Norbert und Grünwald, Viktor
(2020):
Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
In: International Journal of Cancer, Bd. 148, Nr. 7: S. 1685-1694
Grünwald, Viktor; Karch, Annika; Schuler, Markus; Schoeffski, Patrick; Kopp, Hans-Georg; Bauer, Sebastian; Kasper, Bernd; Lindner, Lars H.; Chemnitz, Jens-Marcus; Crysandt, Martina; Stein, Alexander; Steffen, Björn; Richter, Stephan; Egerer, Gerlinde; Ivanyi, Philipp; Zimmermann, Silke; Liu, Xiaofei und Kunitz, Annegret
(2020):
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study.
In: Journal of Clinical Oncology, Bd. 38, Nr. 30
Grünwald, Viktor; Eberhardt, Berit; Bex, Axel; Flörcken, Anne; Gauler, Thomas; Derlin, Thorsten; Panzica, Martin; Duerr, Hans Roland; Grötz, Knut Achim; Giles, Rachel H.; Falck, Christian von; Graser, Anno; Muacevic, Alexander und Stähler, Michael
(2018):
An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
In: Nature Reviews Urology, Bd. 15, Nr. 8: S. 511-521
Schoffski, Patrick; Wozniak, Agnieszka; Escudier, Bernard; Rutkowski, Piotr; Anthoney, Alan; Bauer, Sebastian; Sufliarsky, Jozef; Herpen, Carla van; Lindner, Lars H.; Grünwald, Viktor; Zakotnik, Branko; Lerut, Evelyne; Debiec-Rychter, Maria; Marreaud, Sandrine; Lia, Michela; Raveloarivahy, Tiana; Collette, Sandra und Albiges, Laurence
(2017):
Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial.
In: European Journal of Cancer, Bd. 87: S. 147-163
Eigentler, Thomas K.; Hassel, Jessica C.; Berking, Carola; Aberle, Jens; Bachmann, Oliver; Grünwald, Viktor; Kähler, Katharina C.; Loquai, Carmen; Reinmuth, Niels; Steins, Martin; Zimmer, Lisa; Sendl, Anna und Gutzmer, Ralf
(2016):
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.
In: Cancer Treatment Reviews, Bd. 45: S. 7-18